Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc. is a United States-based biopharmaceutical company focused on developing innovative therapies to target hypertension and kidney diseases. The company's research and development efforts are centered on novel approaches to address unmet medical needs in patients suffering from these conditions. Mineralys Therapeutics aims to improve patient outcomes by creating targeted treatments that offer enhanced efficacy and safety profiles. The company operates within the healthcare and pharmaceutical sectors, contributing to the advancement of medical science through its commitment to innovation and clinical research. Mineralys Therapeutics is dedicated to pioneering solutions that can significantly impact the lives of individuals affected by hypertension and kidney-related ailments, positioning itself as a key player in the development of next-generation therapeutics.